Skip to main content

Table 1 Sociodemographic, anthropometric, and clinical characteristics of individuals with chronic obstructive pulmonary disease at beginning of the study (n = 76)

From: Responsiveness to pulmonary rehabilitation in COPD is associated with changes in microbiota

Characteristics

Intervention group (n = 38)

Control group (n = 38)

p-value

Age (years), mean ± SD

72 ± 9

70 ± 7.60

0.19a

Gender, n (%)

0.57b

 Male

29 (76%)

31 (82%)

 

 Female

9 (24%)

7 (18%)

 

BMI (kg/m2), mean ± SD

26 ± 4

26.4 ± 4.8

0.72c

FEV1PP, mean ± SD

49.2 ± 16.0

52.3 ± 19.8

0.53a

FVCPP, mean ± SD

77.8 ± 17.3

76.9 ± 27.9

0.68a

Pack-years, mean ± SD

42.4 ± 43.0

53.0 ± 51.2

0.27a

Comorbidities (CCI), mean ± SD

4.2 ± 1.4

3.8 ± 1.3

0.10a

GOLD grade, n (%)

0.22d

 1

3 (8%)

6 (16%)

 

 2

14 (37%)

12 (32%)

 

 3

20 (53%)

15 (39%)

 

 4

1 (3%)

5 (13%)

 

GOLD group, n (%)

0.069d

 A

8 (21%)

17 (45%)

 

 B

20 (53%)

12 (32%)

 

 C

0 (0%)

1 (3%)

 

 D

10 (26%)

8 (21%)

 

Medication, n (%)

   

 ICS

21 (55%)

19 (50%)

0.8d

 LABA

33 (87%)

30 (79%)

0.36d

 LAMA

24 (63%)

25 (66%)

 > 0.99

 LTRA

2 (5%)

2 (5%)

 > 0.99d

 SABA

9 (24%)

5 (13%)

0.37d

 SAMA

2 (5%)

0 (5%)

0.49d

 Macrolides in stability

0 (0%)

0 (0%)

 > 0.99

Number of exacerbations in the last year, n (%)

0.60b

 0 or 1

27 (71%)

29 (76%)

 

  ≥ 2 or 1 with a hospitalisation

11 (29%)

9 (24%)

 

Number of hospitalisations in the last year due to COPD, n (%)

0.67d

 0

32 (84%)

34 (89%)

 

 1

2 (5%)

3 (8%)

 

 2

3 (8%)

1 (3%)

 

 Missing values

1 (3%)

0 (0%)

 

mBORG, mean ± SD

0.8 ± 1.3

0.5 ± 1.0

0.3a

CAT, mean ± SD

17.1 ± 8.1

11.7 ± 7.4

0.003a

Walked distance in 6MWT, mean ± SD

389.0 ± 133.9

457.5 ± 82.8

0.045a

  1. SD: standard deviation, n (%): absolute and relative frequency, respectively; BMI: body mass index, FEV1pp: forced expiratory volume in 1 s percent predicted, CCI: charlson comorbidity index; GOLD: global initiative for chronic obstructive lung disease; ICS: inhaled corticosteroids; LABA: long-acting beta agonists, LAMA: long-acting muscarinic agonists, LTRA: leukotriene receptor antagonists, SABA: short-acting beta agonists; SAMA: short-acting muscarinic agonists; ap-value obtained with Mann Whitney U-test; b p-value obtained with Chi-square test; c p-value obtained with unpaired t-test with Welch’s correction; dp-value obtained with Fisher’s exact test